More on TRDA

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+100.0% Growth)
- Ratings (8.6 Score)

Upcoming Events

- Earnings (8/6/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Entrada Therapeutics (NQ:TRDA)
Delayed: 12.58 +0.96 (8.26%)
Prev. Close $11.62  
Open$11.43 
52 Wk High$ 
52 Wk Low$ 
Day High$12.75 
Day Low$11.05 
P/E N/A  
EPS$ 
Volume465,481 

Friends, Peers and Foes (?): BIIB, AMLX, ANAB, ARWR, DRUG (more...)

Mar 6, 2026 04:37 PM Form 4 Entrada Therapeutics, For: Mar 04 Filed by: WENTWORTH KORY JAMES
Mar 4, 2026 05:12 PM Form 144 Entrada Therapeutics, Filed by: WENTWORTH KORY JAMES
Mar 3, 2026 06:21 PM Form 4 Entrada Therapeutics, For: Mar 01 Filed by: Doshi Dipal
Mar 3, 2026 06:21 PM Form 4 Entrada Therapeutics, For: Mar 01 Filed by: WENTWORTH KORY JAMES
Mar 3, 2026 06:20 PM Form 4 Entrada Therapeutics, For: Mar 01 Filed by: Dowden Nathan J
Mar 3, 2026 06:19 PM Form 4 Entrada Therapeutics, For: Mar 01 Filed by: Sethuraman Natarajan
Mar 2, 2026 04:30 PM Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Feb 26, 2026 07:47 AM Form S-8 Entrada Therapeutics,
Feb 26, 2026 07:45 AM Entrada Therapeutics, Inc. (TRDA) Tops Q4 EPS by 4c
Feb 26, 2026 07:10 AM Form 10-K Entrada Therapeutics, For: Dec 31
View All Articles

Entities mentioned with TRDA

View All Entities